021-51111890
购物车（）
sales@molnova.cn
Mequitazine
CAS No. 29216-28-2
Mequitazine ( Mequitazine; Primalan; Mircol; Metaplexan )
产品货号. M18376 CAS No. 29216-28-2
Mequitazine is an effective, nonsedative and long-acting histamine H1 antagonist.
纯度: 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥340 | 有现货 |
|
| 10MG | ￥470 | 有现货 |
|
| 25MG | ￥737 | 有现货 |
|
| 50MG | ￥1004 | 有现货 |
|
| 100MG | ￥1264 | 有现货 |
|
| 200MG | 获取报价 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Mequitazine
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Mequitazine is an effective, nonsedative and long-acting histamine H1 antagonist.
-
产品描述Mequitazine is a potent histamine H1 antagonist or antihistamine. It competes with histamine for the normal H1-receptor sites on effector cells of the gastrointestinal tract, blood vessels and respiratory tract. Mequitazine provides effective, temporary relief of sneezing, watery and itchy eyes, and runny nose due to hay fever and other upper respiratory allergies.
-
同义词Mequitazine; Primalan; Mircol; Metaplexan
-
通路Others
-
靶点Other Targets
-
受体H1 receptor
-
研究领域Inflammation/Immunology
-
适应症——
化学信息
-
CAS Number29216-28-2
-
分子量322.47
-
分子式C20H22N2S
-
纯度98%
-
溶解度DMSO : 16 mg/mL 49.62 mM;
-
SMILESC(C1CN2CCC1CC2)N1c2ccccc2Sc2ccccc12
-
化学全称10-(1-azabicyclo[2.2.2]octan-3-ylmethyl)phenothiazine
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Gonnot V, et al. Expedient synthesis of mequitazine an antihistaminic drug by palladium catalyzed allylic alkylation of sodium phenothiazinate. Chem Pharm Bull (Tokyo). 2009 Nov;57(11):1300-2.
产品手册
关联产品
-
[Ala1,?3,?11,?15]?-?...
[Ala1,3,11,15]-Endothelin (TFA) is a highly selective for endothelin A (ETA) and endothelin B (ETB) receptor.[Ala1,?3,?11,?15]?-?Endothelin is a selective ETB endothelin receptor agonist (IC50 values are 0.33 and 2200 nM for displacing [125I]-ET-1 from ETB and ETA receptors respectively).
-
2-METHYLVALERIC ACID
2-METHYLVALERIC ACID is a natural product.
-
Rebaudioside A
Rebaudioside A is a novel agent of glycoside clathration of pharmacons, acts as α-glucosidase inhibitor.
